J.W. Cole Advisors Inc. Has $425,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

J.W. Cole Advisors Inc. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.3% in the third quarter, Holdings Channel reports. The institutional investor owned 1,045 shares of the company’s stock after acquiring an additional 71 shares during the period. J.W. Cole Advisors Inc.’s holdings in HCA Healthcare were worth $425,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of HCA. State of Alaska Department of Revenue increased its holdings in shares of HCA Healthcare by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 21,590 shares of the company’s stock worth $8,774,000 after purchasing an additional 510 shares during the period. Carret Asset Management LLC grew its holdings in shares of HCA Healthcare by 7.2% during the 3rd quarter. Carret Asset Management LLC now owns 11,087 shares of the company’s stock worth $4,506,000 after purchasing an additional 742 shares in the last quarter. Financial Management Professionals Inc. raised its stake in HCA Healthcare by 54.5% in the third quarter. Financial Management Professionals Inc. now owns 238 shares of the company’s stock valued at $97,000 after purchasing an additional 84 shares in the last quarter. AllGen Financial Advisors Inc. bought a new position in HCA Healthcare in the 3rd quarter valued at about $219,000. Finally, GHP Investment Advisors Inc. lifted its holdings in shares of HCA Healthcare by 15.4% during the 3rd quarter. GHP Investment Advisors Inc. now owns 577 shares of the company’s stock worth $235,000 after acquiring an additional 77 shares during the period. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Wells Fargo & Company upped their target price on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 22nd. Truist Financial lifted their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Oppenheimer boosted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $379.11.

HCA Healthcare Price Performance

HCA stock opened at $358.57 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company’s fifty day simple moving average is $393.62 and its 200 day simple moving average is $353.85. HCA Healthcare, Inc. has a 12-month low of $223.73 and a 12-month high of $417.14. The firm has a market cap of $92.54 billion, a price-to-earnings ratio of 16.10, a PEG ratio of 1.52 and a beta of 1.67.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare’s payout ratio is currently 11.85%.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.